A patient with chronic kidney disease stage 4 develops secondary hyperparathyroidism. Which initial pathophysiological event triggers this hormonal adaptation?

• A Reduced 1-alpha-hydroxylase activity in failing kidneys → decreased 1,25(OH)2 vitamin D3 → reduced calcium absorption → hypocalcemia → PTH stimulation
• B Retained phosphate from reduced GFR directly stimulating parathyroid glands
• C Uremic toxins directly stimulating parathyroid chief cells to produce PTH
• D Both reduced calcitriol and hyperphosphatemia contribute: phosphate retention directly stimulates parathyroids while reduced calcitriol removes tonic inhibition of parathyroid cell proliferation ✓

Explanation

Secondary hyperparathyroidism in CKD is multifactorial. The earliest event is reduced 1-alpha-hydroxylase activity in the damaged kidney, reducing calcitriol (1,25-dihydroxyvitamin D3). Calcitriol normally suppresses PTH gene transcription and inhibits parathyroid cell proliferation; its loss de-represses PTH. Simultaneously, hyperphosphatemia directly stimulates parathyroid cells (via the calcium-sensing receptor independent pathway and direct phosphate sensors) and also reduces ionized calcium (by precipitation). Both mechanisms synergistically drive parathyroid hyperplasia and PTH hypersecretion. Option A describes only part of the mechanism; options B and C are incomplete or incorrect.

Reference: Guyton & Hall, Textbook of Medical Physiology, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.